Tom O'Brien


Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.


Eclipse Launches Highly Anticipated MicroPen EVO™, Health Canada Approved Automated Micro-Needling Device

DALLASMarch 3, 2020 /PRNewswire/ — After the successful launch of MicroPen Elite, a medical-grade micro-needling device, Eclipse, a US-based medical device manufacturer, is excited to introduce Canada and the world to the next generation MicroPen EVO™!

Now available for sale through its Toronto-based distribution partner, Salient Medical Solutions, MicroPen EVO represents the true evolution of micro-needling technology.

“Our American R&D team thoughtfully crafted a device that takes safety, efficacy and performance to a whole new level,” stated Tom O’Brien, CEO and Founder of Eclipse. “I am confident that the medical community will select MicroPen EVO as their micro-needling pen of choice!”

Eclipse is also honored to announce Dr. Jean Carruthers and Dr. Shannon Humphrey of Vancouver, British Columbia, as the first practice in North America to upgrade to the new MicroPen EVO. Both physicians are respected worldwide as pioneers, innovators and leaders in cosmetic dermatology.

“MicroPen has been a wonderful addition to our armamentarium of skin rejuvenation tools,” Dr. Carruthers said. “We are excited to be the first clinic to upgrade to the new MicroPen EVO!”

Dr. Humphrey added, “Our patients are always looking for natural ways to maintain their youthful appearance. They love that MicroPen harnesses the skin’s natural ability to repair itself.”

Now that MicroPen EVO has arrived in Canada, Salient Medical will be offering a special upgrade program exclusively for their MicroPen Elite customers.

“The anticipation amongst our loyal customer base for the launch of Micropen EVO has been unprecedented,” says Michael Pizzorno, CEO of Salient. “We are grateful to count such incredible physicians as Drs. Carruthers and Humphrey as our partners and look forward to bringing EVO to the rest the medical aesthetic community across Canada.”

For information about other Eclipse products, including Eclipse PRP™ and Votesse™ hair health nutraceutical, visit eclipsemed.com. To be contacted by your Eclipse representative call us at (800) 759-6876 or email info@eclipsemed.com.

Eclipse MicroPen EVO is Health Canada approved.  For more information visit salientmed.com or call Salient Medical at (855) 736-3003.

Eclipse MicroPen EVO™ is pending FDA 510(k) clearance and is not currently available for sale in the USA.

Julie Summerville

SOURCE Eclipse

For USA & Canada visitors: EclipseMedGlobal.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?

Yes, please proceed


Visit the Eclipse USA Site